Physician profile
Hetty Hong
NPI 1659863678
$320.06
in general payments reported to CMS, 2019-2025
10 companies · $71.39 in 2025
The $71.39 reported for 2025 was less than what a typical General Practice (Dentist) provider received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.69 · 2021: $23.49 · 2022: $98.27 · 2023: $43.54 · 2024: $66.68 · 2025: $71.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $182.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $181.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $69.47 | 2022-2024 | |
| Kerr Corporation | $53.72 | 2022-2023 | Maxcem Elite |
| Nobel Biocare USA | $45.26 | 2021-2023 | Nobelactive |
| Orapharma, A Division of Bausch Health US, LLC | $41.66 | 2019-2025 | Arestin |
| Envista Holdings Corporation | $36.73 | 2024-2025 | Maxcem Elite, Harmonize |
| Solventum Corporation | $22.47 | 2025 | Vanish Varnish, 3m Relyx, 3m Scotchbond |
| Philips North America LLC | $17.51 | 2024 | (E55) Oral Health Care Und |
| Voco America INC. | $14.49 | 2022 | |
| Align Technology, INC. | $13.76 | 2022 | |
| Zest Holdings, LLC | $4.99 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hetty Hong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.